Reckitt, Abbott

Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case
The Whitfield family legal case was just one of many still pending relating to the necrotizing enterocolitis (NEC) disease.
Abbott, Reckitt cleared of liability in latest preterm formula case
By Brendan Pierson (Reuters) -Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of their premature baby formulas' risks.
Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win
Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case concerning its baby formulas.
Jury sides with Abbott Laboratories in ongoing fight over preterm infant formulas
A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not liable after a boy consumed the companies’ cow’s milk-based products for premature infants and became severely ill.
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness.
Abbott, Reckitt Unit Defeat Claims in Baby Formula Trial
Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that severely sickened a baby boy.
Abbott jumps as jury says company, Reckitt not liable in infant formula case
Financial writer covers Abbot's 4.3% rise after being found not liable in baby formula lawsuit, along with Reckitt Benckiser.
Abbott, Mead Johnson Win Defense Verdict Over Preemie Infant Formula
In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.
Abbott Laboratories’ Legal Victory Strengthens Future Outlook and Supports Buy Rating
Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...
Lawyer Monthly3h
Missouri Judge Bars Kirkland Partner from Abbott Infant Formula Trial
Missouri Judge Sanctions Kirkland Lawyer, Barring Him from Abbott Infant Formula Trial Over Alleged Misconduct in High-Stakes NEC Case ...
Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win
The ruling by a Missouri state court jury is a rare legal win for Abbott Laboratories, maker of Similac formula, and ...
Abbott, Mead Johnson secure win in infant formula trial, Reuters reports
Abbott (ABT) and Reckitt Benckiser’s (RBGLY) unit Mead Johnson are not responsible for a young boy’s debilitating intestinal ...